Imperial’s STI Deal Buys Out Backers
Toronto-based private equity firm Imperial Capital agreed Wednesday to invest $17 million in Halifax pharmaceutical services company STI Technologies Ltd., which includes the buyout of several existing investors, such as venture capital company GrowthWorks Atlantic.
Steve Nicolle, CEO of the Halifax company, opened a pre-arranged speech at the Invest Atlantic conference by flashing the press release announcing the deal, which will help to finance the company’s expansion.
Though he declined to provide details, Nicolle said a “healthy amount” of the $17 million funding will remain with